|
Volumn 13, Issue SUPPL. 1, 2002, Pages
|
ET-743: The US experience in sarcomas of soft tissues
|
Author keywords
Chemotherapy; Ecteinascidin 743; Soft tissue sarcoma
|
Indexed keywords
AMINOTRANSFERASE;
TRABECTEDIN;
1,3 DIOXOLANE DERIVATIVE;
ALKYLATING AGENT;
ISOQUINOLINE DERIVATIVE;
TETRAHYDROISOQUINOLINE DERIVATIVE;
ADULT;
AGED;
ALOPECIA;
ANTINEOPLASTIC ACTIVITY;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CARDIOTOXICITY;
CONFERENCE PAPER;
CONTROLLED STUDY;
DISEASE COURSE;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
MORTALITY;
MUCOSA INFLAMMATION;
NEUROTOXICITY;
NEUTROPENIA;
PRIORITY JOURNAL;
SOFT TISSUE SARCOMA;
TREATMENT OUTCOME;
TREATMENT PLANNING;
DISEASE FREE SURVIVAL;
DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MULTICENTER STUDY;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
REVIEW;
SARCOMA;
SURVIVAL;
UNITED STATES;
ANTINEOPLASTIC AGENTS, ALKYLATING;
CLINICAL TRIALS, PHASE II;
DIOXOLES;
DISEASE-FREE SURVIVAL;
DRUG ADMINISTRATION SCHEDULE;
HUMAN;
INFUSIONS, INTRAVENOUS;
ISOQUINOLINES;
MULTICENTER STUDIES;
SARCOMA;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
UNITED STATES;
HUMANS;
TETRAHYDROISOQUINOLINES;
|
EID: 0036270843
PISSN: 09594973
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (38)
|
References (9)
|